ARS Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
ARS Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • ARS Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 3.01K %, a 5.34% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 3.01K +153 +5.34% Sep 30, 2024
Q2 2024 3.84K +193 +5.29% Jun 30, 2024
Q1 2024 3.5K -45.5 -1.28% Mar 31, 2024
Q4 2023 2.98K -48.1 -1.59% Dec 31, 2023
Q3 2023 2.86K +615 +27.4% Sep 30, 2023
Q2 2023 3.65K +1.85K +103% Jun 30, 2023
Q1 2023 3.55K +1.71K +93% Mar 31, 2023
Q4 2022 3.03K +847 +38.8% Dec 31, 2022
Q3 2022 2.25K -514 -18.6% Sep 30, 2022
Q2 2022 1.8K Jun 30, 2022
Q1 2022 1.84K Mar 31, 2022
Q4 2021 2.19K Dec 31, 2021
Q3 2021 2.76K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.